Alzheimer's disease (AD) is characterized by extracellular senile plaques in the brain, containing amyloid-β peptide (Aβ). We identify immunological differences between AD patients and age-matched controls greater than those related to age itself. The biggest differences were in the CD4+ rather than the CD8+ T cell compartment resulting in lower proportions of naïve cells, more late-differentiated cells and higher percentages of activated CD4+CD25+ T cells without a Treg phenotype in AD patients. Changes to CD4+ cells might be the result of chronic stimulation by Aβ present in the blood. These findings have implications for diagnosis and understanding the aetiology of the diseas
<p>The neuropathological hallmarks of Alzheimer’s disease (AD), i.e., neuritic plaques and neurofibr...
Patients with Alzheimer dementia display evidence of amyloid-related neurodegeneration. Our focus wa...
AbstractAlzheimer's disease (AD) is a neurodegenerative disease that leads to the progressive deteri...
Alzheimer's disease (AD) is characterized by extracellular senile plaques in the brain, containing a...
Alzheimer’s disease (AD), a chronic multifactorial and complex neurodegenerative disorder is a leadi...
The main subject of this doctoral work is the role of the immune system in Alzheimer's di...
To investigate the systemic signs of immune-inflammatory responses in Alzheimer\u2019s disease (AD),...
INTRODUCTION Fast and minimally invasive approaches for early diagnosis of Alzheimer's disease (A...
Alzheimer’s Disease is the most common form of dementia and is the fifth-leading cause of death in p...
Objectives: Among several other factors, the neuro-toxic β-amyloid peptide (βAP)-induced inflammator...
Abstract Studies over the last 100 years have suggested a link between inflammation, infectious dise...
This study examines the link between peripheral immune changes in perpetuation of the Alzheimer's di...
Inflammatory processes are important in the pathogenesis of Alzheimer's disease and in response to a...
The neuropathological hallmarks of Alzheimer’s disease (AD), i.e., neuritic plaques and neurofibrill...
Immune system and blood–brain barrier dysfunction are implicated in the development of Alzheimer’s a...
<p>The neuropathological hallmarks of Alzheimer’s disease (AD), i.e., neuritic plaques and neurofibr...
Patients with Alzheimer dementia display evidence of amyloid-related neurodegeneration. Our focus wa...
AbstractAlzheimer's disease (AD) is a neurodegenerative disease that leads to the progressive deteri...
Alzheimer's disease (AD) is characterized by extracellular senile plaques in the brain, containing a...
Alzheimer’s disease (AD), a chronic multifactorial and complex neurodegenerative disorder is a leadi...
The main subject of this doctoral work is the role of the immune system in Alzheimer's di...
To investigate the systemic signs of immune-inflammatory responses in Alzheimer\u2019s disease (AD),...
INTRODUCTION Fast and minimally invasive approaches for early diagnosis of Alzheimer's disease (A...
Alzheimer’s Disease is the most common form of dementia and is the fifth-leading cause of death in p...
Objectives: Among several other factors, the neuro-toxic β-amyloid peptide (βAP)-induced inflammator...
Abstract Studies over the last 100 years have suggested a link between inflammation, infectious dise...
This study examines the link between peripheral immune changes in perpetuation of the Alzheimer's di...
Inflammatory processes are important in the pathogenesis of Alzheimer's disease and in response to a...
The neuropathological hallmarks of Alzheimer’s disease (AD), i.e., neuritic plaques and neurofibrill...
Immune system and blood–brain barrier dysfunction are implicated in the development of Alzheimer’s a...
<p>The neuropathological hallmarks of Alzheimer’s disease (AD), i.e., neuritic plaques and neurofibr...
Patients with Alzheimer dementia display evidence of amyloid-related neurodegeneration. Our focus wa...
AbstractAlzheimer's disease (AD) is a neurodegenerative disease that leads to the progressive deteri...